|
Symbol
|
RMA93V | RMBA5V | CBRBKB | RMBAQV | AAPGTQ | KYPQDU | AASJTQ | RMA72V | OSDRCH | RMAPBV | RMALEV | OVHRCH | RMBNOV | KZBIDU | ABWMSQ | CIEBKB | RMA54V | RMBRQV | PEZRCH | ABKBTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Basiswert
|
Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Clariant AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Adecco Group AG / Sandoz Group AG / Sika AG | Alcon / Sandoz Group AG / Sonova Hldg. AG / Straumann Hldg. AG | Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Lonza Group N / Sandoz Group AG / Sonova Hldg. AG / Straumann Hldg. AG | Alcon / Novartis AG / Sandoz | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG / Straumann Hldg. AG | Clariant AG / Sandoz Group AG / Tecan Group AG | Bachem Hldg. AG / Novartis AG / Roche PS / Sandoz Group AG | Sandoz Group AG / Sika AG / Stadler Rail AG | Clariant AG / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Alcon / Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Givaudan / Lonza Group N / Sandoz Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
12.01.2027 | 05.01.2027 | 02.11.2026 | 09.02.2027 | 12.08.2026 | 21.08.2026 | 26.08.2026 | 31.08.2026 | 19.08.2026 | 07.09.2026 | 15.03.2027 | 16.09.2026 | 26.10.2026 | 30.10.2026 | 30.10.2026 | 18.11.2026 | 02.11.2026 | 22.11.2027 | 18.11.2026 | 12.11.2026 |
| Geld | 96.80 | 97.00 | 93.41 | 100.10 | - | 76.35 | 101.50 | 94.30 | 101.32 | 70.10 | 73.00 | 70.79 | 100.40 | 79.60 | 79.76 | 96.95 | 98.90 | 90.50 | 93.15 | 97.66 |
| Brief | 97.80 | 98.00 | - | 101.10 | - | 77.35 | - | - | - | - | - | - | 101.60 | 80.60 | - | 97.75 | 99.90 | 91.50 | - | 98.46 |